CD69 and colorectal cancer: We also measured T cell activation against a collection of CEA-positive or CEA-negative cell lines, including three patient-derived CEA-positive colorectal cancer cell lines, using a Jurkat reporter cell line (J69), modified by CRISPR to express tdTomato under the control of the CD69 promoter.